One of the best in vitro models developed to date has been lipoma cell cultures derived from patients carrying germline mutations in PTEN, which are sensitive to sirolimus (the clinical name for rapamycin), which slows their growth (Leipert et al., 2016; Schmid et al., 2014; Wang et al., 2007). This evidence concerns the gene PTEN and lipoma.